By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Thursday that its first-quarter revenues increased 30 percent, with a particularly strong quarter for its assay sales.

The Austin, Texas-based multiplex diagnostics and research products firm brought in total revenues of $33.3 million for the three-month period ended March 31, compared to $25.6 million for the first quarter of 2009. The firm beat analysts' consensus estimate for revenue of $32.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.